A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
The purpose of this study is to create a resource of biospecimens (bodily fluids/samples) from people with Primary Sclerosing Cholangitis (PSC) and to use these samples for current and future research relating to PSC.
Doctors at Indiana University School of Medicine are conducting a study for patients with Cystic Fibrosis (CF) to understand how CF and certain medications for CF affect the health of bone and muscle. This is not a drug or treatment study.
Researchers in the IU School of Public Health are looking for volunteers to take part in a study to better understand the stressors experienced by people as they go about their everyday lives. Individuals between 50 and 64 years of age who are able to use a smartphone intermittently throughout …
The purpose of this study is to investigate the effectiveness of two different walking training procedures on the recovery of mobility, walking and other measures of health in individuals with motor incomplete spinal cord injury.
The goal of this project is to obtain blood samples and test to see how each individual’s body is responding to traumatic injuries in order to better understand how to treat patients with injuries like these in the future.
Researchers at Indiana University School of Nursing/Riley Children's Hospital are looking for children and their parents/caregivers to take part in a study to find out how play activities, like stories and music, can be used to help lower young child and caregiver stress and improve quality of life during cancer …
In this research study, we want to learn more about treatment of sickle cell anemia (SCA). Imatinib is a medication that is commonly used to treat certain types of cancers. Imatinib has not been approved to treat SCA or any pain associated with anemia and is considered an investigational treatment …
This study is being done in order to see how ruxolitinib changes the breast cell when administered to participants with premalignant breast conditions.